...
首页> 外文期刊>Journal of Immunological Methods >Generation of chimeric monoclonal antibodies from mice that carry human immunoglobulin Cgamma1 heavy of Ckappa light chain gene segments.
【24h】

Generation of chimeric monoclonal antibodies from mice that carry human immunoglobulin Cgamma1 heavy of Ckappa light chain gene segments.

机译:从携带人免疫球蛋白Cgamma1重Ckappa轻链基因片段的小鼠中产生嵌合单克隆抗体。

获取原文
获取原文并翻译 | 示例
           

摘要

Gene targeting in mouse embryonic stem (ES) cells was used to replace (i) the mouse immunoglobulin heavy chain (IgH) Cgamma2a gene segment (mCgamma2a) with the human Cgamma1 gene segment (hCgamma1), and (ii) the mouse immunoglobulin light chain (IgL) Ckappa gene segment (mC kappa) with its human counterpart (hC kappa). ES cells carrying these gene conversions were used to generate chimeric mice that transmitted the human alleles through the germ line. Mice homozygous for both gene alterations were generated by breeding. Serum from homozygous mutant mice contained comparable amounts of antibodies with chimeric kappa or mouse lambda light chains but only small fractions of basal serum IgG or antibodies elicited against immunizing agents contained chimeric heavy chains. A relative increase in immunogen-specific hCgamma1 antibodies was seen following immunization in combination with the saponin adjuvant QS-21. The effect of this was to shift the IgG1-dominated response to an IgG subclass profile that included significant amounts of IgG2a, IgG2b and IgG3 and chimeric IgG. The amounts of antibody secreted by hybridomas derived from mutant and wild-type mice were similar. Sequencing confirmed correct splicing of hCgamma1 and hCkappa gene segments to mouse J gene segments in hybridoma Ig gene transcripts. In conclusion, IgHhCgamma1/IgLhCkappa double mutant mice provide a useful animal model for deriving humanized antibodies with potential applications in immunotherapy and diagnostics in vivo as well as for investigating hCgamma1 associated functions.
机译:小鼠胚胎干(ES)细胞中的基因靶向用于将(i)小鼠免疫球蛋白重链(IgH)Cgamma2a基因片段(mCgamma2a)替换为人Cgamma1基因片段(hCgamma1),以及(ii)小鼠免疫球蛋白轻链(IgL)Ckappa基因区段(mC kappa)及其人类对应物(hC kappa)。携带这些基因转换的ES细胞用于产生嵌合小鼠,该小鼠通过种系传播人类等位基因。通过育种产生两种基因改变的纯合小鼠。来自纯合突变小鼠的血清含有相当数量的具有嵌合κ或小鼠​​λ轻链的抗体,但是仅一小部分的基础血清IgG或针对免疫剂引起的抗体含有嵌合重链。结合皂苷佐剂QS-21进行免疫后,免疫原特异性hCgamma1抗体相对增加。这样做的作用是将IgG1主导的反应转变为IgG亚类谱,其中包括大量IgG2a,IgG2b和IgG3和嵌合IgG。来自突变型和野生型小鼠的杂交瘤分泌的抗体数量相似。测序证实了hCgamma1和hCkappa基因片段与杂交瘤Ig基因转录物中的小鼠J基因片段的正确剪接。总之,IgHhCgamma1 / IgLhCkappa双重突变小鼠提供了有用的动物模型,可用于衍生人源化抗体,在体内免疫治疗和诊断中具有潜在的应用,以及用于研究hCgamma1相关功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号